La investigación traslacional en la oncología clínica: retos y oportunidades

作者: E. Díaz-Rubio

DOI: 10.1016/S1130-6343(10)70001-5

关键词:

摘要: The principal objective of the translational research in Oncology is to translate knowledge derived from basic clinical practice as soon possible. goal develop and maximize concepts oncopharmacogenomic oncopharmacogenetic. In this context it will be absolutely necessary that hospitals integrate units with appropriate resources.

参考文章(38)
RPh Claiborne E. Reeder, and Debra Gordon, Managing oncology costs. The American Journal of Managed Care. ,vol. 12, ,(2006)
Ministerio de Sanidad, Premios a la calidad en el ámbito del sistema nacional de salud Ministerio de Sanidad, Política Social e Igualdad. ,(2010)
Rosa Rodríguez-Monguió, Fernando Antoñanzas Villar, Healthcare Rationing in Spain PharmacoEconomics. ,vol. 24, pp. 537- 548 ,(2006) , 10.2165/00019053-200624060-00002
S. Edwin Fineberg, Thomas T. Kawabata, Deborah Finco-Kent, Robert J. Fountaine, Gregory L. Finch, Alan S. Krasner, Immunological responses to exogenous insulin. Endocrine Reviews. ,vol. 28, pp. 625- 652 ,(2007) , 10.1210/ER.2007-0002
John A Vernon, Scott J Johnson, W Keener Hughen, Antonio Trujillo, Economic and Developmental Considerations for Pharmacogenomic Technology PharmacoEconomics. ,vol. 24, pp. 335- 343 ,(2006) , 10.2165/00019053-200624040-00004
P Pirazzoli, E Cacciari, M Mandini, A Cicognani, S Zucchini, T Sganga, M Capelli, Follow-up of antibodies to growth hormone in 210 growth hormone-deficient children treated with different commercial preparations. Acta Paediatrica. ,vol. 84, pp. 1233- 1236 ,(1995) , 10.1111/J.1651-2227.1995.TB13539.X
H. Schellekens, When biotech proteins go off-patent Trends in Biotechnology. ,vol. 22, pp. 406- 410 ,(2004) , 10.1016/J.TIBTECH.2004.06.003
Fernando Antoñanzas, Roberto Rodríguez, José Antonio Sacristán, Rafael Illa, Los medicamentos en la Unión Europea: el tándem comercio-salud Gaceta Sanitaria. ,vol. 19, pp. 151- 167 ,(2005) , 10.1157/13074370
Samantha C. Gouw, Johanna G. van der Bom, Günter Auerswald, Carmen Escuriola Ettinghausen, Ulf Tedgård, H. Marijke van den Berg, Recombinant versus plasma-derived factor VIII products and the development of inhibitors in previously untreated patients with severe hemophilia A: the CANAL cohort study Blood. ,vol. 109, pp. 4693- 4697 ,(2007) , 10.1182/BLOOD-2006-11-056317
A EVENS, C BENNETT, S LUMINARI, Epoetin-induced pure red-cell aplasia (PRCA): preliminary results from the research on adverse drug events and reports (RADAR) group. Best Practice & Research Clinical Haematology. ,vol. 18, pp. 481- 489 ,(2005) , 10.1016/J.BEHA.2005.01.017